Stay updated on Fostamatinib and Ruxolitinib in Myelofibrosis Clinical Trial

Sign up to get notified when there's something new on the Fostamatinib and Ruxolitinib in Myelofibrosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fostamatinib and Ruxolitinib in Myelofibrosis Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-04-30T14:01:24.000Z thumbnail image
  3. Check
    23 days ago
    Change Detected
    Summary
    The page has undergone significant changes, including the removal of detailed information about the treatment of myelofibrosis with fostamatinib, which included specific criteria for inclusion and exclusion in a clinical study. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.
    Difference
    25%
    Check dated 2025-04-16T10:11:54.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T05:09:10.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T22:19:02.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-03-03T23:11:59.000Z thumbnail image
  7. Check
    88 days ago
    Change Detected
    Summary
    The page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    1%
    Check dated 2025-02-10T16:42:38.000Z thumbnail image

Stay in the know with updates to Fostamatinib and Ruxolitinib in Myelofibrosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fostamatinib and Ruxolitinib in Myelofibrosis Clinical Trial page.